SummaryResearchers from University College London (UCL) have found that taking semaglutide drugs such as Ozempic, Wegovy, Rybelsus can reduce the risk of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) by four percent for every 5kg less body weight or 5cm smaller waist